michigan glp-1 nausea lawsuit Ozempic – July 2026 Update Pennsylvania's Hershey Company says it
Description
*Obesity GLP-1 Ozempic and Mounjaro Source: IQVIA Analysis
The deal, which includes Eli Lilly and Novo Nordisk, will slash prices for Medicare and Medicaid programme recipients.
The metabolite-gene layer revealed enrichment in galactose metabolism, platelet homeostasis, and nitric-oxide pathways
In a patient health record study, semaglutide was associated with strong reductions in indicators of tobacco use among diabetes patients with a history of tobacco use disorder.

Safety issues like the black box warning for thyroid cancer risk are also addressed

Obesity medicine physician Jessica Duncan discusses the article "GLP-1 weight regain: Why stopping medication leads to weight return." Jessica explains that expecting to maintain weight loss after abruptly stopping GLP-1 therapy is unrealistic because it ignores the physiological forces that defend a person's prior weight
